Back to Agendas
[V2-S6] Perspectives for Development of Regenerative Medical Products in PMD Act
Session Chair(s)
Teruo Okano, PhD
Professor, Institute of Advanced BioMedical Engineering and Science
Tokyo Women's Medical University, Japan
For the promotion of Regenerative medicine in Japan, new special definitions and a section for regenerative medical products were established under “the PMD Act” (partially revised Pharmaceutical Affairs Law). Medical innovations are to be shared by all the beneficiaries, and international regulatory communication channels are to be developed to share the views on the new development. In this session, considering these new environments, the perspectives of industry and academia for developing regenerative medical products and cooperating will be discussed.
Speaker(s)
Perspectives for Development of Regenerative Medical Products in Japanese Industry
Keiji Yoshimura
Japan Tissue Engineering Co., Ltd., Japan
Department of Regulatory Affairs
The Role of Academia for Developing Regenerative Medical Products
Kiyoshi Okada, MD, PhD
Osaka University Hospital, Japan
Vice Director, Medical Ctr for Translational Research,Dept of Medical Innovation
Perspectives for Global Development of Regenerative Medical Products
Yasuko Terao, PhD
Takeda Pharmaceutical Co., Ltd., Japan
Head, External Scientific Engagement, R&D Japan Region,
Expectation for Development of Regenerative Medical Products from Academic Society
Akihiro Umezawa, MD, PhD
National Center for Child Health and Development, Japan
Deputy Director
Have an account?